I think the grind up will commence in the next two weeks....

I think the grind up will commence in the next two weeks. Possibly even early next week.

Albeit low volume trading, there is notable attrition in the offer side liquidity. Feels like I’m calling this way too early, but I sense the selling is beginning to fatigue.

I cannot see any fundamental reason to sell the stock here, apart from timeline disappointment. Which is of course fair if your holding period cannot accommodate another 6m wait for FDA. However on a risk tolerance basis, absent of the extended wait we face, the company carries less risk now at 13.5c than it did at 18c. The selling is technical and when it’s exhausted, we grind up, probably on light volume. That’s what forecast happening here.